MME and autosomal dominant cerebellar ataxia: Detailed characterization of the CD10 C143Y quality control and degradation pathway, and the biosynthetic pathway of WT CD10, would offer vital insights for application in SCA treatment, as well as for diseases associated with immature secretory and membrane proteins involved in ER quality control systems.